当前位置: 首页 > 期刊 > 《中国当代医药》 > 2012年第20期
编号:12276549
肝细胞癌的诊治进展(4)
http://www.100md.com 2012年7月15日 《中国当代医药》 2012年第20期
     [19] Mazzaferro V,Regalia E,Doci R,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med,1996,334(11):693-699.

    [20] Pelletier SJ,Fu S,Thyagarajan V,et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using Organ Procurement Transplant Network data[J]. Liver Transpl,2009,15(8):859-868.

    [21] Cho YK,Kim JK,Kim MY,et al. Systematic review of randomizedtrials for hepatocellular carcinoma treated with percutaneous ablation therapies[J]. Hepatology,2009,49(2):453-459.

    [22] Bruix J,Sala M,Llovet JM. Chemoembolization for hepatocellular carcinoma[J]. Gastroenterology,2004,127(5):179-188.

    [23] Salem R,Lewandowski RJ,Mulcahy MF,et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres:a comprehensive report of longterm outcomes[J]. Gastroenterology,2010,138(1):52-64.

    [24] Llovet JM,Ricci S,Mazzaferro V,et al. Sorafenib in advanced hepatocellular carcinoma[J]. N Engl J Med,2008,359(4):378-390.

    (收稿日期:2012-04-20 本文编辑:陈 俊), 百拇医药(张焕荣 张俊芳 张培帅)
上一页1 2 3 4